Hello, everyone, and how are you today? The Pharmalot corporate campus is humming this morning as we hustle the short people off to their school houses and the official mascots are yapping endlessly. This calls, as you can imagine, for a cup or two of stimulation - our flavor today is Cinnamon Cream Swirl - and hope you will join us. After two weeks of vacation and holidays, we are finally getting caught up with our workload. But we continue to welcome new insights and interesting tips, so please pass them along. Meanwhile, here are some items to get you started. Have a great day...
Vivus Diet Pill Covered More Often Than Anticipated (Bloomberg News)
Former J&J CEO Who Managed Tylenol Scare Dies (Wall Street Journal)
FDA Asks Judge To Dismiss Employee 'Spying' Suit (Bloomberg News)
Merck KGgA Has Redeployed Part Of Serono Staff (InPharm)
Children Underrepresented In Clinical Trials (HealthDay)
Lundbeck And Takeda Seek FDA Approval For Antidepressant (Reuters)
FDA To Hold Patient-Focused Development Meeting (Pharma Times)
Merck And Ablynx Ink Nanobody Deal Worth Up To $578M (Reuters)
J&J To Expand Puerto Rico Operations (Associated Press)
Sanofi Shows Impressive Results For Oral Gaucher Drug (Pharma Times)
Quintiles To Boost Clinical Trials In Scotland (Outsourcing Pharma)
BioInvent Cuts More Jobs (Pharma Times)
EDITOR'S NOTE: Please check this post for updates